Birth weight and neonatal morbidity as early-life risk factors for childhood cancer: a nationwide cohort study
View abstract on PubMed
Summary
This summary is machine-generated.Low birth weight and certain neonatal complications significantly increase childhood cancer risk. Interventions like oxygen therapy and transfusions in premature infants may also play a role in cancer development.
Area Of Science
- Neonatal care and pediatric oncology.
- Epidemiology of childhood cancers.
- Perinatal factors influencing long-term health outcomes.
Background
- Childhood cancer risk is influenced by perinatal factors, but neonatal interventions' impact is unclear.
- Understanding the interplay between birth weight, neonatal morbidities, and cancer is crucial.
Purpose Of The Study
- To investigate the association between birth weight and childhood cancer risk.
- To explore how neonatal morbidities and interventions modulate this relationship.
Main Methods
- Nationwide population-based cohort study in South Korea (2008-2014 births).
- Analysis of cancer incidence up to 2018 using National Health Insurance Service data.
- Categorization by birth weight and assessment of neonatal conditions and interventions.
Main Results
- Low birth weight (<1.0 kg) infants showed a 4-fold increased risk of childhood cancer.
- Specific cancers linked to birth weight: hepatoblastoma (<1.5 kg), CNS malignancies (1.5-2.4 kg), leukemia (>4.0 kg).
- In low birth weight infants, bronchopulmonary dysplasia, sepsis, prolonged oxygen exposure, and multiple transfusions increased cancer risk.
Conclusions
- Both birth weight extremes and neonatal exposures contribute to childhood cancer risk.
- Bronchopulmonary dysplasia, sepsis, oxygen therapy, and transfusions may affect oncogenic pathways in low birth weight infants.
- Long-term follow-up and research into biological mechanisms in high-risk neonates are recommended.
Related Concept Videos
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Selection Bias: This occurs when the study population is not...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...

